What's happening
Writing a plain-English summary… Track this bill to get it by email.
Why it matters
Albany, before your first meeting.
Every bill that moved yesterday, summarized in a sentence and ranked by impact. The Albany Scorecard follows on Sundays.
Free. Unsubscribe in one click. Want alerts on specific bills? Create an account.
Who cares
Headline styles
Sponsors
No co-sponsors yet.
History
- Referred to insurance
- Referred to insurance
Companion bill
The same bill in the other chamber. A bill becomes law when one version passes both houses and the governor signs it, so either number can carry it.
Authorizes reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs
In Assembly Committee · Insurance · Sponsor Jeffrey Dinowitz
Full text
The text isn't available here yet. Check nysenate.gov.
Sponsor's memo
BILL NUMBER:S2880
Title of bill
An act to amend the insurance law, in relation to reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs
Purpose or general idea of bill
To authorize reimbursement for testing for familial dysautonomia, Canavan's disease and Tay-Sachs
Summary of provisions
Amends subsection (1) of Section 3216, subsection (1) of Section 3221 and Section 4303 of the Insurance Law, to authorize reimbursement for Familial Dysautonomia, Canavan's disease and Tay-Sachs testing.
The bill also states that in order to maintain the confidentiality of persons tested, receipt of acknowledgment from the testing facility shall be deemed sufficient evidence of testing.
Justification
Familial Dysautonomia, Canavan's disease and Tay-Sachs are genetic diseases which cause degeneration of the nervous system, and result in death. No treatment is currently available for any of these diseases, however, an infant can only be afflicted with the disease if both the mother and father are carriers. There is currently a testing system in place which screens individuals before marriage to determine if they are carriers. This legislation would insure that individuals are able to receive reimbursement for medical screening for these diseases through their insurance carrier.
Prior legislative history
2011: A.264 2010: S.7977 2009-10: A.1134 Referred to Insurance 2007-08: A.4447 Referred to Insurance 2005-06: A.2424-A Referred to Insurance 2003-04: A.9263 Referred to Insurance
Fiscal implications
None.
Effective date
Immediately.
Summaries, headlines and scores are AI-generated from the official bill text. How we score bills. Source: NYS Open Legislation.